Merck has begun construction of a $3 billion, 400,000-square-foot pharmaceutical manufacturing facility at its Elkton, VA site. Merck’s investment in the Center of Excellence for Pharmaceutical Manufacturing is part of a more than $70 billion investment beginning in 2025 to expand domestic manufacturing and research and development to drive its long-term growth strategy. “Today is an important milestone for Merck, for Virginia, for manufacturing in the United States and, most importantly, ...